Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Capital Expenditures (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Capital Expenditures readings, the most recent being $2411.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures changed N/A to $2411.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $9055.0, a 94.3% decrease, with the full-year FY2025 number at $6644.0, down 95.84% from a year prior.
  • Capital Expenditures hit $2411.0 in Q1 2026 for Pharma-Bio Serv, up from $350.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $157015.0 in Q4 2024 to a low of -$1580.0 in Q4 2023.
  • Median Capital Expenditures over the past 5 years was $2061.5 (2022), compared with a mean of $13951.3.
  • Biggest five-year swings in Capital Expenditures: tumbled 113.02% in 2023 and later skyrocketed 10037.66% in 2024.
  • Pharma-Bio Serv's Capital Expenditures stood at $12137.0 in 2022, then crashed by 113.02% to -$1580.0 in 2023, then skyrocketed by 10037.66% to $157015.0 in 2024, then tumbled by 99.78% to $350.0 in 2025, then skyrocketed by 588.86% to $2411.0 in 2026.
  • The last three reported values for Capital Expenditures were $2411.0 (Q1 2026), $350.0 (Q4 2025), and $2036.0 (Q3 2025) per Business Quant data.